The Influence of Education During Waiting Time of Vaccination on the Knowledge Towards COVID-19 Among Chinese Residents
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT05033860|
Recruitment Status : Recruiting
First Posted : September 5, 2021
Last Update Posted : September 5, 2021
|Condition or disease||Intervention/treatment||Phase|
|Covid19 Knowledge, Attitudes, Practice||Other: Read leaflets containing knowledge of COVID-19 and vaccination.||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||312 participants|
|Intervention Model:||Single Group Assignment|
|Intervention Model Description:||
|Official Title:||The Influence of Education During Waiting Time of Vaccination on the Knowledge Towards COVID-19 Among Chinese Residents: A Randomized Controlled Trial|
|Actual Study Start Date :||August 18, 2021|
|Estimated Primary Completion Date :||September 20, 2021|
|Estimated Study Completion Date :||September 20, 2021|
Experimental: Intervention group
Leaflets containing knowledge of COVID-19 and vaccination were distributed, and questionnaire surveys were conducted afterwards.
Other: Read leaflets containing knowledge of COVID-19 and vaccination.
Leaflets containing knowledge of COVID-19 and vaccination were distributed, and participants are asked to read the leaflets.
No Intervention: Control group
Questionnaire surveys were conducted without leaflets distribution.
- Scores of the questionnaire [ Time Frame: 5-20 minutes ]All the participants are asked to fulfill a questionnaire entitled "A survey on the public knowledge of COVID-19 and vaccination". The total score of questionnaire is calculated (full mark is 24). A higher score means a better knowledge of COVID-19 and vaccination.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05033860
|Contact: Lei Xu, MDfirstname.lastname@example.org|
|Contact: Siyi Yuemail@example.com|
|Ningbo First Hospital||Recruiting|
|Ningbo, Zhejiang, China, 315010|
|Contact: Lei Xu 13486659126 firstname.lastname@example.org|